Gene Variant Explains Rare Brain Disorder CAMRQ1
Families with unexplained CAMRQ1-like symptoms may benefit from genetic testing that now includes this newly identified VLDLR variant.
Updated on Nov. 4, 2026 in Diseases — General

Researchers identified a novel genetic variant in the VLDLR gene causing CAMRQ1, a rare brain-development disorder, in four siblings from one family. The study, published in Human Mutation, also reports the first genetically confirmed CAMRQ1 case on the African continent.
Why it matters
Rare diseases affect an estimated 300 million people worldwide, and many remain undiagnosed because genetic data from Africa and other regions is limited. Confirming a specific gene variant gives clinicians a clearer route to molecular diagnosis for families with similar symptoms.
This is a family-level genetic study of four siblings using whole-exome sequencing, with functional lab analyses of the resulting protein. Because it examines one family, the findings identify a causal variant but do not measure how frequently it occurs in broader populations.
The players
Dr Pedro Rodríguez
Leads the Human Genetics Team at CNAG, a genomics research center that conducts sequencing and rare-disease genetics work.
United Arab Emirates University
A research university that collaborated on the family-level genetic investigation of this rare disorder.
University Cheikh Anta Diop
A university in Senegal that partnered on the study and contributed to genetic research on rare disease in Africa.
The details
The team found a novel homozygous missense variant in the VLDLR gene, meaning affected children inherited two copies of the altered gene, one from each carrier parent. Laboratory analysis showed the resulting p.(P565Q) VLDLR protein is retained in the endoplasmic reticulum, a cellular compartment, and cannot reach the plasma membrane where it normally functions. This disruption is what links the genetic change to the disorder's features. Researchers at CNAG collaborated with United Arab Emirates University and the University Cheikh Anta Diop in Senegal on the work.
Timeline
The study was published in Human Mutation; the publication date is not specified in the source.
Health Landscape
Prior CAMRQ1 cases had been described in the Middle East, Europe and East Asia, but none had been genetically confirmed in Africa until this report. The finding adds African population data to a rare-disease diagnostic landscape where limited regional databases have made molecular diagnosis difficult.
If you have a family history of unexplained developmental or brain-related conditions, it is worth raising genetic testing with your doctor, since molecular diagnosis can clarify causes that are otherwise hard to identify. Families of people with rare neurological conditions should discuss with a clinician whether genetic evaluation is appropriate.
The takeaway
Genetic sequencing can identify causes of rare brain-development disorders that were previously unexplained, and this study adds African data to that effort. If you have concerns about a family history of similar conditions, discuss genetic testing options with your physician.
Further reading
For broader context on conditions like this, explore our Diseases — General coverage.
More information
Read the original Human Mutation study identifying novel VLDLR variant for the full genetic and functional findings.
Source note: This article includes information reported by Biotech-spain.


